Annual EBITDA
$6.11B$802.00M+15.11%
Summary
- Current Value
- As of today, SYK annual EBITDA is $6.11B, up +15.11% on
- Historical Performance
- SYK annual EBITDA is up +31.39% over the past 3 years, and up +46.69% over the past 5 years
- All-Time High Comparison
- SYK annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- SYK annual EBITDA is +29.14% above its 3-year low of $4.73B reached on an earlier date
- Sector Comparison
- SYK annual EBITDA is higher than 98.05% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $6.11B | +15.1% | +31.4% | +46.7% | +189.7% | |
| Quarterly EBITDA | $1.67B | +17.2% | +52.2% | +49.8% | +205.7% | |
| TTM EBITDA | $6.65B | +15.2% | +44.3% | +81.7% | +194.6% | |
| Price | $366.39 | +1.4% | +43.0% | +51.1% | +570.5% | |
| PE Ratio | 48.11 | +3.4% | +15.8% | -16.6% | +180.8% | |
| Annual Revenue | $22.60B | +10.2% | +32.1% | +51.8% | +236.1% | |
| Annual EPS | $7.76 | -5.9% | +48.8% | +41.6% | +180.2% | |
| Annual EBIT | $5.06B | +18.2% | +38.2% | +49.4% | +193.6% | |
| Annual Net Income | $2.99B | -5.4% | +50.1% | +43.7% | +170.3% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $6.11B | at high | |
| 5Y | $6.11B | at high | |
| All | $6.11B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $4.73B | N/A | +29.1% |
| 5Y | $3.76B | N/A | +62.5% |
| All | $5.89M | >+9999.0% |
EBITDA History
FAQ
What is the current annual EBITDA of SYK?
As of today, SYK annual EBITDA is $6.11B
What is 1-year change in SYK annual EBITDA?
SYK annual EBITDA is up +15.11% year-over-year
What is 3-year change in SYK annual EBITDA?
SYK annual EBITDA is up +31.39% over the past 3 years
How far is SYK annual EBITDA from its all-time high?
SYK annual EBITDA is currently at its all-time high
How does SYK annual EBITDA rank versus sector peers?
SYK annual EBITDA is higher than 98.05% of companies in Healthcare sector
When is SYK next annual earnings release?
The next annual earnings release for SYK is on
Quarterly EBITDA
$1.67B$16.00M+0.97%
Summary
- Current Value
- As of today, SYK quarterly EBITDA is $1.67B, up +0.97% on
- Historical Performance
- SYK quarterly EBITDA is up +17.16% year-over-year, and up +52.23% over the past 3 years
- All-Time High Comparison
- SYK quarterly EBITDA is currently -13.18% below its historical high of $1.93B set on
- 3-Year Low Comparison
- SYK quarterly EBITDA is +50.04% above its 3-year low of $1.12B reached on
- Sector Comparison
- SYK quarterly EBITDA is higher than 97.92% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $1.67B | +1.0% | +17.2% | +52.2% | +49.8% | |
| Annual EBITDA | $6.11B | – | +15.1% | +31.4% | +46.7% | |
| TTM EBITDA | $6.65B | +3.8% | +15.2% | +44.3% | +81.7% | |
| Price | $366.39 | +0.0% | +1.4% | +43.0% | +51.1% | |
| PE Ratio | 48.11 | +0.0% | +3.4% | +15.8% | -16.6% | |
| Quarterly Revenue | $6.06B | +0.6% | +10.3% | +35.2% | +62.1% | |
| Quarterly EPS | $2.22 | -2.9% | +2.7% | +3.9% | +36.0% | |
| Quarterly EBIT | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Quarterly Net Income | $859.00M | -2.8% | +3.0% | +5.3% | +38.3% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.93B | N/A | -13.2% |
| 3Y | $1.93B | -13.2% | |
| 5Y | $1.93B | -13.2% | |
| All | $1.93B | -13.2% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.40B | +19.8% | |
| 3Y | $1.12B | +50.0% | |
| 5Y | $1.00B | +66.6% | |
| All | -$104.50M | +1701.0% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of SYK?
As of today, SYK quarterly EBITDA is $1.67B
What is SYK quarterly EBITDA most recent change?
SYK quarterly EBITDA was up +0.97% on September 30, 2025
What is 1-year change in SYK quarterly EBITDA?
SYK quarterly EBITDA is up +17.16% year-over-year
How far is SYK quarterly EBITDA from its all-time high?
SYK quarterly EBITDA is currently -13.18% below its historical high of $1.93B set on December 31, 2024
How does SYK quarterly EBITDA rank versus sector peers?
SYK quarterly EBITDA is higher than 97.92% of companies in Healthcare sector
When is SYK next earnings release?
The next earnings release for SYK is on
TTM EBITDA
$6.65B$245.00M+3.82%
Summary
- Current Value
- As of today, SYK TTM EBITDA is $6.65B, up +3.82% on
- Historical Performance
- SYK TTM EBITDA is up +15.16% year-over-year, and up +44.25% over the past 3 years
- All-Time High Comparison
- SYK TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- SYK TTM EBITDA is +40.60% above its 3-year low of $4.73B reached on an earlier date
- Sector Comparison
- SYK TTM EBITDA is higher than 97.92% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $6.65B | +3.8% | +15.2% | +44.3% | +81.7% | |
| Annual EBITDA | $6.11B | – | +15.1% | +31.4% | +46.7% | |
| Quarterly EBITDA | $1.67B | +1.0% | +17.2% | +52.2% | +49.8% | |
| Price | $366.39 | +0.0% | +1.4% | +43.0% | +51.1% | |
| PE Ratio | 48.11 | +0.0% | +3.4% | +15.8% | -16.6% | |
| TTM Revenue | $24.38B | +2.4% | +10.9% | +35.8% | +71.5% | |
| TTM EPS | $7.62 | +0.8% | -18.4% | +18.5% | +64.9% | |
| TTM EBIT | $4.15B | -21.9% | -12.5% | +14.3% | +44.1% | |
| TTM Net Income | $2.94B | +0.9% | -18.0% | +19.8% | +67.6% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $6.65B | at high | |
| 3Y | $6.65B | at high | |
| 5Y | $6.65B | at high | |
| All | $6.65B | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $6.03B | N/A | +10.3% |
| 3Y | $4.73B | N/A | +40.6% |
| 5Y | $3.75B | N/A | +77.5% |
| All | -$32.20M | >+9999.0% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of SYK?
As of today, SYK TTM EBITDA is $6.65B
What is SYK TTM EBITDA most recent change?
SYK TTM EBITDA was up +3.82% on September 30, 2025
What is 1-year change in SYK TTM EBITDA?
SYK TTM EBITDA is up +15.16% year-over-year
How far is SYK TTM EBITDA from its all-time high?
SYK TTM EBITDA is currently at its all-time high
How does SYK TTM EBITDA rank versus sector peers?
SYK TTM EBITDA is higher than 97.92% of companies in Healthcare sector
When is SYK next earnings release?
The next earnings release for SYK is on
EBITDA Formula
Data Sources & References
- SYK Official Website www.stryker.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/310764/000031076425000129/0000310764-25-000129-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/310764/000031076425000023/0000310764-25-000023-index.htm
- SYK Profile on Yahoo Finance finance.yahoo.com/quote/SYK
- SYK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/syk